| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteome | 5 | 2022 | 34 | 1.730 |
Why?
|
| Proteomics | 5 | 2018 | 92 | 1.670 |
Why?
|
| Ginsenosides | 5 | 2012 | 5 | 1.300 |
Why?
|
| Panax | 5 | 2011 | 8 | 1.220 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2012 | 85 | 0.790 |
Why?
|
| Platelet Aggregation | 3 | 2012 | 21 | 0.740 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 548 | 0.690 |
Why?
|
| Neuromyelitis Optica | 1 | 2016 | 1 | 0.570 |
Why?
|
| Cerebrospinal Fluid | 1 | 2016 | 13 | 0.570 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 141 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 252 | 0.540 |
Why?
|
| Exosomes | 1 | 2016 | 39 | 0.540 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 43 | 0.540 |
Why?
|
| Macaca mulatta | 2 | 2022 | 323 | 0.510 |
Why?
|
| Pancreatic Neoplasms | 2 | 2013 | 133 | 0.510 |
Why?
|
| Histones | 1 | 2014 | 49 | 0.490 |
Why?
|
| Plant Roots | 2 | 2011 | 3 | 0.480 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 80 | 0.450 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 313 | 0.450 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 208 | 0.420 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 302 | 0.400 |
Why?
|
| Complement Inactivating Agents | 1 | 2011 | 2 | 0.390 |
Why?
|
| Complement Pathway, Classical | 1 | 2011 | 2 | 0.390 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2021 | 20 | 0.380 |
Why?
|
| Animals | 15 | 2022 | 7339 | 0.370 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 692 | 0.310 |
Why?
|
| Humans | 20 | 2022 | 29552 | 0.290 |
Why?
|
| Plant Extracts | 4 | 2011 | 60 | 0.280 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2014 | 50 | 0.260 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2015 | 57 | 0.260 |
Why?
|
| Mice | 7 | 2022 | 2387 | 0.260 |
Why?
|
| Male | 12 | 2022 | 18012 | 0.260 |
Why?
|
| Mass Spectrometry | 4 | 2022 | 100 | 0.260 |
Why?
|
| Rats | 4 | 2015 | 1609 | 0.250 |
Why?
|
| Oxidation-Reduction | 3 | 2022 | 251 | 0.240 |
Why?
|
| Female | 12 | 2022 | 18379 | 0.230 |
Why?
|
| Pyrimidines | 2 | 2013 | 60 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 10 | 0.210 |
Why?
|
| Receptor, EphA4 | 1 | 2022 | 1 | 0.210 |
Why?
|
| Sulfhydryl Compounds | 1 | 2022 | 33 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 57 | 0.200 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 15 | 0.190 |
Why?
|
| Apoptosis | 3 | 2019 | 352 | 0.190 |
Why?
|
| Melanoma | 1 | 2022 | 148 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2013 | 93 | 0.180 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2010 | 5 | 0.180 |
Why?
|
| Diet, Reducing | 1 | 2020 | 90 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 83 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 748 | 0.170 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 14 | 0.170 |
Why?
|
| Vasoconstrictor Agents | 2 | 2010 | 62 | 0.170 |
Why?
|
| Hindlimb Suspension | 1 | 2019 | 11 | 0.170 |
Why?
|
| Adiposity | 1 | 2020 | 192 | 0.170 |
Why?
|
| Space Flight | 1 | 2019 | 19 | 0.170 |
Why?
|
| Collagen | 2 | 2010 | 218 | 0.160 |
Why?
|
| Cocaine | 1 | 2022 | 266 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 88 | 0.160 |
Why?
|
| Cartilage, Articular | 1 | 2019 | 72 | 0.160 |
Why?
|
| Hip Joint | 1 | 2019 | 57 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2016 | 173 | 0.160 |
Why?
|
| Chromatography, Liquid | 2 | 2015 | 42 | 0.160 |
Why?
|
| Knee Joint | 1 | 2019 | 129 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2020 | 332 | 0.150 |
Why?
|
| Weight Loss | 1 | 2020 | 416 | 0.150 |
Why?
|
| Muscle Denervation | 1 | 2017 | 28 | 0.150 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 106 | 0.150 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2017 | 29 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2019 | 224 | 0.150 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2013 | 34 | 0.140 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 37 | 0.140 |
Why?
|
| Fibronectins | 1 | 2016 | 34 | 0.140 |
Why?
|
| Troponin T | 1 | 2017 | 64 | 0.140 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2015 | 10 | 0.130 |
Why?
|
| Sequence Analysis, Protein | 1 | 2015 | 4 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 179 | 0.130 |
Why?
|
| Databases, Protein | 1 | 2015 | 13 | 0.130 |
Why?
|
| Cattle | 1 | 2015 | 100 | 0.130 |
Why?
|
| Iron | 1 | 2015 | 113 | 0.120 |
Why?
|
| Software | 1 | 2015 | 110 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2022 | 228 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2013 | 69 | 0.120 |
Why?
|
| Thiazoles | 1 | 2013 | 32 | 0.120 |
Why?
|
| Cell Movement | 1 | 2014 | 161 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 199 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 33 | 0.120 |
Why?
|
| Benzamides | 1 | 2013 | 54 | 0.110 |
Why?
|
| Piperazines | 1 | 2013 | 56 | 0.110 |
Why?
|
| Indoles | 1 | 2013 | 59 | 0.110 |
Why?
|
| Arachidonic Acid | 2 | 2012 | 35 | 0.110 |
Why?
|
| Mebendazole | 1 | 2013 | 1 | 0.110 |
Why?
|
| Sulfanilamides | 1 | 2013 | 1 | 0.110 |
Why?
|
| Veterinary Drugs | 1 | 2013 | 1 | 0.110 |
Why?
|
| Food Analysis | 1 | 2013 | 3 | 0.110 |
Why?
|
| Pyrroles | 1 | 2013 | 55 | 0.110 |
Why?
|
| Porphyria, Acute Intermittent | 1 | 2013 | 13 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 933 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 43 | 0.110 |
Why?
|
| Cell Survival | 1 | 2013 | 278 | 0.110 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2012 | 1 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2012 | 38 | 0.110 |
Why?
|
| Metabolome | 1 | 2012 | 31 | 0.110 |
Why?
|
| Food Inspection | 1 | 2012 | 1 | 0.100 |
Why?
|
| Food Contamination | 1 | 2012 | 2 | 0.100 |
Why?
|
| Appetite Depressants | 1 | 2012 | 6 | 0.100 |
Why?
|
| Algorithms | 1 | 2015 | 468 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 643 | 0.100 |
Why?
|
| Iris Plant | 1 | 2011 | 1 | 0.100 |
Why?
|
| Complement Fixation Tests | 1 | 2011 | 1 | 0.100 |
Why?
|
| Chemical Fractionation | 1 | 2011 | 2 | 0.100 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 19 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 163 | 0.090 |
Why?
|
| Rotavirus | 1 | 2010 | 4 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2011 | 45 | 0.090 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 5 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2010 | 13 | 0.090 |
Why?
|
| Acetylation | 1 | 2010 | 13 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 78 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 18 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2012 | 172 | 0.090 |
Why?
|
| Aging | 1 | 2017 | 891 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 71 | 0.090 |
Why?
|
| Sheep | 1 | 2011 | 224 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2010 | 101 | 0.090 |
Why?
|
| Betula | 1 | 2008 | 1 | 0.080 |
Why?
|
| Plant Proteins | 1 | 2008 | 13 | 0.080 |
Why?
|
| Triterpenes | 1 | 2008 | 4 | 0.080 |
Why?
|
| Adult | 3 | 2016 | 8528 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2008 | 38 | 0.080 |
Why?
|
| Hydroxyl Radical | 1 | 2008 | 3 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 38 | 0.080 |
Why?
|
| Middle Aged | 3 | 2016 | 10936 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 984 | 0.070 |
Why?
|
| Metabolomics | 2 | 2020 | 46 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 1120 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 389 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 680 | 0.060 |
Why?
|
| Limit of Detection | 2 | 2013 | 15 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 3764 | 0.050 |
Why?
|
| GMP Reductase | 1 | 2022 | 1 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 8 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 16 | 0.050 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2022 | 3 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2015 | 861 | 0.050 |
Why?
|
| Kinetics | 1 | 2022 | 206 | 0.050 |
Why?
|
| Syndrome | 1 | 2022 | 66 | 0.050 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2021 | 3 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2021 | 30 | 0.050 |
Why?
|
| Computational Biology | 1 | 2021 | 86 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2020 | 13 | 0.050 |
Why?
|
| Amino Acids | 1 | 2020 | 41 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 92 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2020 | 64 | 0.050 |
Why?
|
| Hippocampus | 1 | 2021 | 185 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 475 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 249 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2021 | 264 | 0.040 |
Why?
|
| Aged | 3 | 2020 | 9590 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 74 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 40 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2019 | 76 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 825 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 15 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 23 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 77 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2021 | 423 | 0.040 |
Why?
|
| Antioxidants | 1 | 2019 | 114 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2018 | 82 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2018 | 178 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 283 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.040 |
Why?
|
| Cysteine | 1 | 2018 | 131 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 85 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2017 | 67 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 713 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2017 | 114 | 0.040 |
Why?
|
| Action Potentials | 1 | 2017 | 175 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 115 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2015 | 29 | 0.030 |
Why?
|
| Ferritins | 1 | 2015 | 46 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 127 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 484 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 243 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 2014 | 0.030 |
Why?
|
| Melatonin | 1 | 2013 | 2 | 0.030 |
Why?
|
| Porphobilinogen | 1 | 2013 | 8 | 0.030 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2013 | 26 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2013 | 61 | 0.030 |
Why?
|
| Heme | 1 | 2013 | 60 | 0.030 |
Why?
|
| Thromboxane B2 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Vimentin | 1 | 2012 | 9 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 14 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2012 | 23 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 60 | 0.030 |
Why?
|
| Protein Transport | 1 | 2012 | 75 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 39 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 50 | 0.030 |
Why?
|
| Cyclobutanes | 1 | 2012 | 2 | 0.030 |
Why?
|
| Photometry | 1 | 2012 | 3 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2012 | 8 | 0.030 |
Why?
|
| Aspirin | 1 | 2012 | 66 | 0.030 |
Why?
|
| Anti-Obesity Agents | 1 | 2012 | 6 | 0.030 |
Why?
|
| Carbolines | 1 | 2012 | 9 | 0.030 |
Why?
|
| Androgens | 1 | 2012 | 25 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2012 | 22 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2012 | 286 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2013 | 489 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 141 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2012 | 111 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 523 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2011 | 3 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 14 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 321 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 257 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 158 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 638 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2010 | 4 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 42 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 302 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 177 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 55 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 81 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 574 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 456 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 37 | 0.020 |
Why?
|
| Maillard Reaction | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2008 | 11 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2008 | 10 | 0.020 |
Why?
|
| Cisplatin | 1 | 2008 | 70 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 30 | 0.020 |
Why?
|
| Superoxides | 1 | 2008 | 17 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 25 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 11 | 0.020 |
Why?
|
| Light | 1 | 2008 | 25 | 0.020 |
Why?
|
| Ethanol | 1 | 2011 | 186 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 74 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 165 | 0.020 |
Why?
|